In the last trading session, 1.64 million CorMedix Inc (NASDAQ:CRMD) shares changed hands as the company’s beta touched 1.62. With the company’s per share price at $12.04 changed hands at $0.84 or 7.50% during last session, the market valuation stood at $695.43M. CRMD’s last price was a premium, traded about 6.81% off its 52-week high of $11.22. The share price had its 52-week low at $2.57, which suggests the last value was 78.65% up since then. When we look at CorMedix Inc’s average trading volume, we note the 10-day average is 0.98 million shares, with the 3-month average coming to 858.44K.
Analysts gave the CorMedix Inc (CRMD) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 1 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended CRMD as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. CorMedix Inc’s EPS for the current quarter is expected to be -0.1.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
CorMedix Inc (NASDAQ:CRMD) trade information
Instantly CRMD was in green as seen at the end of in last trading. With action 19.33%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 220.21%, with the 5-day performance at 19.33% in the green. However, in the 30-day time frame, CorMedix Inc (NASDAQ:CRMD) is 64.93% up. Looking at the short shares, we see there were 9.27 million shares sold at short interest cover period of 9.45 days.
The consensus price target for the stock as assigned by Wall Street analysts is 9, meaning bulls need a downside of -33.78% from its current market value. According to analyst projections, CRMD’s forecast low is 9 with 9 as the target high. To hit the forecast high, the stock’s price needs a 25.25% surge from its current level, while the stock would need to tank 25.25% for it to hit the projected low.
CorMedix Inc (CRMD) estimates and forecasts
Data shows that the CorMedix Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 120.92% over the past 6 months, a 36.26% in annual growth rate that is considerably higher than the industry average of 17.20%.
Consensus estimates given by 4 financial analysts project the company’s revenue in the current quarter to hit an average of 10.84M. 4 analysts are of the opinion that CorMedix Inc’s revenue for the current quarter will be 18.23M.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 9.58%. The 2024 estimates are for CorMedix Inc earnings to increase by 31.21%.
CRMD Dividends
CorMedix Inc is expected to release its next quarterly earnings report in November.
CorMedix Inc (NASDAQ:CRMD)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 1.02% of CorMedix Inc shares while 29.89% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 30.20%. There are 29.89% institutions holding the CorMedix Inc stock share, with BLACKROCK INC. the top institutional holder. As of 2024-06-30, the company held 6.1796% of the shares, roughly 3.55 million CRMD shares worth $15.39 million.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 5.0476% or 2.9 million shares worth $12.57 million as of 2024-06-30.
